Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study

Trial Profile

Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Dec 2017

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Warfarin
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RE-LY
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 01 Dec 2017 Status changed from recruiting to completed.
    • 18 Sep 2017 Planned End Date changed from 9 Aug 2017 to 30 Oct 2017.
    • 18 Sep 2017 Planned primary completion date changed from 9 Aug 2017 to 30 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top